bioasia.in - about bioasia

:: Welcome | BioAsia ::

Bioasia.in Spined HTML

:: Welcome | BioAsia :: Home Sitemap -- Quick Links -- Home The focus Organizers FABA Pharmexcil Industry Speak BioAsia 2012 BioAsia 2011 BioAsia 2010 BioAsia 2009 Proceedings 2012 Proceedings 2011 Proceedings 2010 Proceedings 2009 Awards-2012 Awards-2011 Awards-2010 Awards-2009 Photo Gallery 2012 Photo Gallery 2011 Photo Gallery 2010 Photo Gallery 2009 Video Gallery 2012 Video Gallery 2011 Presentation Publications Contact Us home well-nigh bioasia Focus Organizers industry speak archives bioAsia 2012 bioAsia 2011 bioAsia 2010 bioAsia 2009 Gallery Photo Video Presentation publications NewsTrack contact usWell-nighBioAsia Archives Gallery Publications Industry Speak Dr. Seth Berkley, CEO, GAVI Alliance India is a prime example of how the vaccine landscape has reverted over the past 20 years.... Dr. Krishna M. Ella, CMD, Bharat Biotech International Ltd., Hyderabad BioAsia over the years has been instrumental in showcasing the Lifesciences and R&D strengths of Hyderabad and Andhra Pradesh to ... Dr. K V Balasubramaniam, Managing Director, Indian Immunologicals Ltd. More professionally conducted this time with largest industry participation Dr. KV Raghavan, VP, FABA "Indian Biotech industry had crossed over 3$ billion in 2010-2011 and BioAsia is an integral part of the Biotech industry's growth." Dr. Krishna M. Ella, CMD, Bharat Biotech International Ltd., Hyderabad BioAsia over the years has been instrumental in showcasing the Lifesciences and R&D strengths of Hyderabad and Andhra Pradesh ... Vishal Gandhi, SVP and Head- Life Sciences, Yes Bank "It was a truly a vibrant platform and discussions were very stimulating unmistakably suggesting a road map to take the Indian biotech industry to next level of growth." Roopesh Bhargava, Director - Sales & Marketing, Sanofi Pasteur India (Pvt) Ltd., Mumbai "It was indeed a pleasure peekaboo the BioAsia 2012 at Hyderabad. It was a very well thought off coordinated effort to put such a conference. My personal compliments to the team. The Agenda and the subject was very well chosen" Dr. Shreemanta K Parida, CEO, Vaccine Grand Challenge Program, Dept of Biotechnology, Ministry of Science & Technology, Govt. of India I commend BioAsia2012 organisers for making an effort to bring various stakeholders virtually the table in a breakfast meeting with Seth Berkley ... Dr. Harish Iyer, CEO, Shantha Biotech, Hyderabad "This was an spanking-new meeting with topics discussed stuff unmistakably relevant to vaccines and expanding use for resurgence of public health" Mr. Manni Kantipudi, Chief Executive Officer, GVK Biosciences "The BioAsia 2012 was well organized, had good speakers and was well attended. The focus on CROs was important for HYDERABAD to project". Dr. K V Balasubramaniam, Managing Director, Indian Immunologicals Ltd. "More professionally conducted this time with largest industry participation" Mr. Karikal Valaven, IAS, Convener, BioAsia 2012 The precise number of registered delegates for the event was 598; in wing over 450 visitors moreover thronged the three-day global bio-business event ... Dr. Krishna Ella, Chairman and Managing Director, Bharat Biotech International Ltd. Over the years, BioAsia has wilt an industry oriented event while the Bangalore India Bio event has remained research oriented ... Dr. Richard Connell, Vice President and Head of Asia Research, Pfizer, Shanghai "There were some interesting discussions and it was good to meet merchantry partners at the location. The logistics (layout of rooms, food, location) were all very comfortable." Mr. Sai D. Prasad, VP –MerchantryDevelopment, Bharat Biotech International Ltd. "BioAsia 2012 was well organized." BioAsia Organizers Click on logo... T&C Privacy Notice For optimal viewing of this website, recommended browsers are Internet Explorer 7 and whilom versions, Chrome, Firefox and Safari This website can be weightier viewed in 1152 x 864 screen resolution.